Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia. Cesaro E, Falanga AP, Catapano R, Greco F, et al. PLoS One 2022;17:e0266090.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cesaro E, Falanga AP, Catapano R, Greco F, et al. Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia. PLoS One 2022;17:e0266090.
PMID: 35358273